Huntington National Bank’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6K | Buy |
322
+195
| +154% | +$6.44K | ﹤0.01% | 1773 |
|
|
2025
Q1 | $5.1K | Buy |
127
+11
| +9% | +$442 | ﹤0.01% | 1974 |
|
|
2024
Q4 | $5.46K | Sell |
116
-34
| -23% | -$1.6K | ﹤0.01% | 1972 |
|
|
2024
Q3 | $7.92K | Buy |
150
+36
| +32% | +$1.9K | ﹤0.01% | 1840 |
|
|
2024
Q2 | $6.18K | Sell |
114
-130
| -53% | -$7.04K | ﹤0.01% | 1859 |
|
|
2024
Q1 | $17.1K | Buy |
244
+48
| +24% | +$3.37K | ﹤0.01% | 1518 |
|
|
2023
Q4 | $16.4K | Sell |
196
-53
| -21% | -$4.43K | ﹤0.01% | 1480 |
|
|
2023
Q3 | $7.34K | Sell |
249
-16
| -6% | -$471 | ﹤0.01% | 1675 |
|
|
2023
Q2 | $8.64K | Sell |
265
-95
| -26% | -$3.1K | ﹤0.01% | 1609 |
|
|
2023
Q1 | $12.7K | Buy |
360
+47
| +15% | +$1.65K | ﹤0.01% | 1460 |
|
|
2022
Q4 | $14.3K | Buy |
313
+75
| +32% | +$3.44K | ﹤0.01% | 1385 |
|
|
2022
Q3 | $12K | Hold |
238
| – | – | ﹤0.01% | 1471 |
|
|
2022
Q2 | $9K | Hold |
238
| – | – | ﹤0.01% | 1595 |
|
|
2022
Q1 | $9K | Buy |
238
+6
| +3% | +$227 | ﹤0.01% | 1626 |
|
|
2021
Q4 | $11K | Buy |
232
+1
| +0.4% | +$47 | ﹤0.01% | 1547 |
|
|
2021
Q3 | $8K | Sell |
231
-125
| -35% | -$4.33K | ﹤0.01% | 1487 |
|
|
2021
Q2 | $7K | Buy |
356
+30
| +9% | +$590 | ﹤0.01% | 1505 |
|
|
2021
Q1 | $8K | Buy |
+326
| New | +$8K | ﹤0.01% | 1372 |
|
|
2014
Q1 | – | Sell |
-151
| Closed | – | – | 1260 |
|
|
2013
Q4 | $0 | Hold |
151
| – | – | ﹤0.01% | 1720 |
|
|
2013
Q3 | $1K | Buy |
151
+45
| +42% | +$298 | ﹤0.01% | 1706 |
|
|
2013
Q2 | $1K | Buy |
+106
| New | +$1K | ﹤0.01% | 1686 |
|